Few companies have raised their outlook as aggressively as Legence has over the past year, and few stocks have been treated as harshly since the last report. The mechanical and electrical contractor lifted its 2026 revenue forecast for a second straight quarter, posted record backlog and won credit upgrades, yet the shares have fallen 41% since then while the S&P 500 slipped less than 3%. That disconnect makes the third-quarter report, due before the open on November 12, less about whether Legence can clear the bar and more about whether it can persuade the market that the momentum is durable.
The Street is looking for earnings of $0.50 a share on revenue of $1.24 billion. That revenue figure sits just under the $1.25 billion midpoint of management's $1.225 billion to $1.275 billion guidance range, so analysts have essentially taken the company at its word without stretching. It also implies roughly flat sequential sales from the second quarter's $1.26 billion, which grew 111% from a year earlier, about 60% organically. The jump expected in per-share profit from last quarter's $0.17 points to a much cleaner earnings picture, and a quarter free of the sort of charges that dented the prior period. With full-year revenue guidance of $4.70 billion to $4.80 billion and adjusted EBITDA guidance of $565 million to $585 million, both raised sharply three months ago, a simple in-line print may not be enough to shift the conversation.
The most important evidence will be in backlog and margins. Backlog and awards reached a record $5.7 billion last quarter, up from $3.1 billion a year earlier, but quarterly book-to-bill cooled to 1.2 times against 1.4 times on a trailing basis. Management attributed that to lumpy data center awards that now often exceed $100 million apiece. Another sequential gain in backlog would support the idea that demand is extending into 2028 and 2029; a dip would invite questions about whether the lumpiness is masking a slowdown. On profitability, adjusted EBITDA margin expanded about 90 basis points to 12.2% and adjusted SG&A fell to 6.9% of revenue. Holding those levels would confirm that operating leverage is real rather than a one-quarter mix benefit.
The newer growth engines deserve scrutiny too. Semiconductor revenue grew more than 50% and reshoring-driven manufacturing work has grown to roughly the size of the mixed-use business. Management also added fabrication capacity, reaching 1.5 million square feet, and raised capex by $15 million to $20 million to support it. Evidence that this capacity is filling, and that semiconductor and manufacturing awards are showing up in backlog, would broaden the story beyond data centers. On the other side of the ledger, the engineering and consulting segment grew only 6%, design revenue fell 4%, and the sustainability consulting business tied to commercial real estate deteriorated enough to trigger an impairment. Further erosion there would be a manageable but unwelcome drag.
Sentiment has swung from modestly bearish ahead of the last report to modestly bullish now, suggesting some investors see the selloff as overdone. The chart tells a grimmer tale. At $39.16, the stock trades far below its 200-day moving average of $63.25 and sits near the bottom of a post-earnings range of $35.06 to $70.17, a band well beneath the prior quarter's $52.56 to $107.24. The market is clearly pricing in doubt that fundamentals have not yet confirmed.
Ultimately, the question is whether Legence can show that its rising backlog converts into sustained margin expansion. Reaffirming or nudging up full-year targets, with backlog still climbing and leverage still near or below 1.5 times, would reinforce a narrative the stock has stopped believing. A soft bookings quarter or margin slippage, by contrast, would give the skeptics the confirmation they appear to be waiting for.